This content is machine translated Bladder Cancer Effective treatment even in advanced stages Carcinoma of the urinary bladder is one of the common malignant diseases. While the prognosis of patients with superficial tumors is usually favorable, the situation is much worse for muscle-infiltrating…
View Post 4 min This content is machine translated Gastrointestinal oncology From the gastrointestinal tract to the bladder and back In Switzerland, over 4000 people are diagnosed with bowel cancer every year. It does not cause any symptoms for a long time, so early detection is particularly important. Another component…
View Post 4 min This content is machine translated Urooncology From diagnosis to therapy: Urological tumors in focus Annually, the American Society of Clinical Oncology Congress addresses the current state of research on urogenital tumors. The latest study results regarding diagnosis and therapy of prostate cancer, renal cell…
View Post 10 min This content is machine translated Advanced urothelial carcinoma of the urinary bladder Systemic therapy With approximately 1150 new cases annually in Switzerland, urothelial carcinoma of the urinary bladder is one of the most common cancers of older age. Particularly in the metastatic setting, it… CME-Test
View Post 4 min This content is machine translated Metastatic urothelial carcinoma of the urinary bladder Therapy in transition Despite the pandemic, this year’s Swiss Oncology and Hematology Congress (SOHC) was held face-to-face – with more than 1300 participants. Metastatic urothelial carcinoma of the urinary bladder was also a…
View Post 10 min This content is machine translated Advanced urothelial carcinoma of the urinary bladder Systemic therapy With approximately 1150 new cases annually in Switzerland, urothelial carcinoma of the urinary bladder is one of the most common cancers of older age. Particularly in the metastatic setting, it… CME-Test
View Post 7 min This content is machine translated Urothelial carcinoma The role of checkpoint inhibitors Immunotherapy is also becoming increasingly important in the treatment of urothelial carcinoma. Checkpoint inhibitors are already being used successfully, particularly in advanced tumors. Now, potential applications of avelumab, atezolizumab and…
View Post 8 min This content is machine translated Urothelial carcinoma of the urinary bladder A challenge even in times of immune checkpoint inhibitors Urothelial carcinoma accounts for 90% of urinary bladder tumors. Every year, 1250 people in Switzerland contract the disease – predominantly older men. Standard treatment is cisplatin-containing chemotherapy. Immunotherapy is playing…
View Post 2 min This content is machine translated Bladder Cancer Immunotherapy after chemo may prolong survival Carcinoma of the urinary bladder is one of the common malignant diseases. While the prognosis of patients with superficial tumors is usually favorable, the situation is much worse for muscle-infiltrating…
View Post 4 min This content is machine translated Checkpoint Inhibitors Urothelial carcinoma of the urinary bladder – system therapy in transition Checkpoint inhibitors have now become established as a new therapeutic standard in the second-line treatment of metastatic urothelial carcinoma. However, its use could also be useful in first-line therapy.
View Post 8 min This content is machine translated From urinalysis to USPIO MRI Diagnostic options in urothelial carcinoma The basis of diagnosis in urothelial carcinoma is urethrocystoscopy, bladder irrigation cytology, and computed tomography with excretion phase. Image-enhancing techniques increase the diagnostic accuracy of urethrocystoscopy and thus may improve…
